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Abstract—Previous studies have demonstrated a protective effect of the cyclin-dependent kinase (CDK) inhibitor p27Kip1
against atherosclerosis and restenosis, two disorders characterized by abundant proliferation and migration of vascular
smooth muscle cells and adventitial fibroblasts. These therapeutic effects might result from p27Kip1-dependent
suppression of both cell proliferation and migration. However, the interplay between cell growth and locomotion
remains obscure. We show here that p27Kip1 inhibits cellular changes that normally occur during cell locomotion (eg,
lamellipodia formation and reorganization of actin filaments and focal adhesions). Importantly, a p27Kip1 mutant lacking
CDK inhibitory activity failed to inhibit vascular smooth muscle cell and fibroblast proliferation and migration.
Moreover, a constitutively active mutant of the retinoblastoma protein (pRb) insensitive to CDK-dependent hyperphos-
phorylation inhibited both cell proliferation and migration. In contrast, inactivation of pRb by forced expression of the
adenoviral oncogene E1A correlated with high proliferative and migratory activity. Collectively, these results suggest
that cellular proliferation and migration are regulated in a coordinated manner by the p27Kip1/CDK/pRb pathway. These
findings might have important implications for the development of novel therapeutic strategies targeting the
fibroproliferative/migratory component of vascular occlusive disorders. (Circ Res. 2003;92:402-410.)
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Excessive proliferation and migration of vascular smoothmuscle cells (VSMCs) and adventitial fibroblasts play an
important role in the pathobiology of vascular occlusive
disease (eg, atherosclerosis, in-stent restenosis, transplant
vasculopathy, and vessel bypass graft failure).1,2 Thus, un-
derstanding the molecular mechanisms that control hyper-
plastic growth and the locomotion of vascular cells should aid
in the development of novel therapeutic strategies to reduce
neointimal thickening.
Cell cycle progression is controlled by several cyclin-
dependent kinases (CDKs) that associate with regulatory
cyclins.3 Mitogenic stimuli activate CDK/cyclin holoen-
zymes, thus causing hyperphosphorylation of the retinoblas-
toma protein (pRb) and related “pocket” proteins from mid G1
to mitosis. CDK-dependent pRb hyperphosphorylation re-
leases E2F transcription factors, thus contributing to the
expression of several growth and cell cycle–regulatory genes
with functional E2F-binding sites in their promoters.4
Interaction of CDKs/cyclins with CDK inhibitory proteins
(CKIs) attenuates CDK activity and promotes growth arrest.5
CKIs of the Cip/Kip family (p21Cip1, p27Kip1, and p57Kip2) bind
to and inhibit a wide spectrum of CDK/cyclin holoenzymes,
whereas members of the Ink4 family (p16Ink4a, p15Ink4b,
p18Ink4c, and p19Ink4d) are specific for cyclin D–associated
CDKs. Mitogenic and antimitogenic stimuli affect the rates of
synthesis and degradation of CKIs as well as their redistri-
bution among different CDK/cyclin pairs.5 For example,
p27Kip1 promotes the assembly of CDK4/cyclin D complexes,
thus facilitating CDK2/cyclin E activation through the G1/S
phase. Moreover, the proto-oncogene c-myc plays a key role
in p27 sequestration through modulation of the level of cyclin
D and E proteins.
Upregulation of p21Cip1 and p27Kip1 expression at late time
points after experimental balloon angioplasty might limit
neointimal hyperplasia after the initial proliferative wave.6,7
Consistent with this notion, ectopic expression of p21Cip1 and
p27Kip1, but not p16Ink4a, has been shown to significantly
reduce neointimal thickening after angioplasty6,8–12 and vein
grafting.13 The protective role of p27Kip1 against neointimal
thickening has also been demonstrated in hypercholesterol-
emic apolipoprotein-deficient mice, in which genetic inacti-
vation of one or two p27Kip1 alleles progressively accelerated
atherogenesis.14 However, neointimal hyperplasia after me-
chanical damage of the arterial wall was similar in wild-type
and p27Kip1-null mice.15 Redundant roles between p21Cip1 and
p27Kip1 or compensatory increase in p21Cip1 expression (or
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other CKIs) might account for the lack of phenotype of
p27Kip1-null mice in the setting of mechanical arterial injury.
It is also noteworthy to consider several studies with rapa-
mycin, a bacterial macrolide that attenuates experimental
restenosis16,17 and may prevent human in-stent restenosis.18
Rapamycin-dependent growth arrest in cultured cells depends
on the stabilization of p27Kip1.19,20 However, rapamycin failed
to prevent the downregulation of p27Kip1 seen 24 hours after
balloon injury,21 and rapamycin-dependent inhibition of neo-
intimal formation after mechanical injury was similar in
wild-type and p27Kip1-null mice.15 Collectively, these studies
suggest that the protective effect of rapamycin against neo-
intimal thickening is not mediated by p27Kip1.
Regarding the role of CKIs during human atherosclerosis,
more frequent expression of p27Kip1 and p21Cip1 has been
reported within regions of human coronary atheromas not
undergoing proliferation.7 Concordant expression of trans-
forming growth factor- receptors I and II in virtually all cells
positive for p27Kip1 within human atherosclerotic plaques
indicates that the transforming growth factor-1 present in
these lesions may contribute to p27Kip1 upregulation.22 More-
over, coexpression of p53 and p21Cip1 in human carotid
atheromatous plaque cells that revealed a lack of proliferation
markers suggests that an induction of p21Cip1 may occur via
transcriptional activation by p53.23
Recent studies have implicated p21Cip1 and p27Kip1 as
negative regulators of vascular cell migration in vitro. First,
the sensitivity of VSMCs to the antimigratory activity of
rapamycin depends on p27Kip1.24 Second, overexpression of
p27Kip1 and p21Cip1 reduced human vein endothelial cell
(HUVEC) and VSMC migration in vitro.25–27 Thus, protec-
tion against neointimal thickening by these CKIs might result
from the combination of growth suppression and migration
blockade. Although the mechanisms responsible for p27Kip1-
and p21Cip1-dependent growth arrest have been extensively
investigated, how these CKIs exert their antimigratory func-
tion remains unknown. In the present study, we examined the
molecular mechanisms underlying the antimigratory function
of p27Kip1 in VSMCs and fibroblasts and investigated the
interplay between cell proliferation and migration. Our find-
ings suggest that the p27Kip1/CDK/pRb pathway coordinately
regulates cell proliferation and migration.
Materials and Methods
Cell Culture, Retroviral Infection, and
Proliferation Assays
Primary VSMCs were obtained from explant cultures of aortic tissue
from adult Sprague-Dawley rats (Harlan Interfauna Iberica, Barce-
lona, Spain). E19P cells (gift from C. Shanahan, Addenbrooke’s
Hospital, Cambridge, UK) have been described previously.27a These
cells expressed smooth muscle 22, calponin, and smooth muscle
-actin mRNAs (C. Shanahan, PhD, personal communication,
2001). NIH-3T3 cells were obtained from the American Type
Culture Collection. Cells were incubated at 37°C in a humidified 5%
CO2/95% O2 atmosphere in DMEM supplemented with 100 U/mL
penicillin, 0.1 mg/mL streptomycin, 2 mmol/L L-glutamine, and
either 10% FBS (primary VSMCs, E19P) or 10% NCS (NIH-3T3
cells). Unless otherwise stated, experiments were performed with
cells harvested at subconfluent densities.
Infection with retroviruses was as described.28 Briefly, cells were
seeded 24 hours before infection at 70% to 80% confluence (100-mm
dishes). Viral supernatants were mixed with Polybrene (8 g/mL,
Sigma) and added to cells. After 4 hours at 37°C, viral supernatants
were removed, and cells were incubated with normal growth medium
for 8 hours. This process was repeated twice to improve infection.
Infected cells were selected at least for 36 to 48 hours with 2.5 mg/L
puromycin (Sigma). For E1A rescue experiments, cells were first
infected with retroviral vector (Rev) encoding for E1A (Rev-E1A) or
control Rev-hygro, selected with 100 mg/L hygromycin (Invitrogen),
and infected again with Rev-LacZ or Rev-p27. Doubly infected cells
were selected with both hygromycin and puromycin. The generation
of clones from individual cells requires multiple cell divisions over
a long period of time, an approach that is not possible when dealing
with growth suppressor proteins (eg, p27 and pRb). Thus, in the
present study, we used uncloned pooled populations of antibiotic-re-
sistant cells.
[3H]Thymidine incorporation assays were performed in triplicate
as previously described25 in cultures plated on 24-well culture dishes
at a density of 5103 cells per well and incubated for 4 hours with
[3H]thymidine (1 Ci/mL, Amersham).
Western Blot Analysis and CDK Assay
Whole-cell extracts and Western blot analysis were performed as
described6 with the use of anti-p27Kip1 (1:250) and anti-CDK2
(1:500) antibodies (sc-1641 and sc-163, respectively; Santa Cruz
Biotechnology). Densitometric analysis of the blots was performed
with Labimage version 2.6 software.
CDK activity in cell lysates was determined as described,6 except
that CDK/cyclin holoenzymes were immunoprecipitated with 0.2 g
of each anti-cyclin E (sc-481) and anti-cyclin A (sc-751) antibody.
Migration Assays
Migration of cells labeled with calcein-AM (Molecular Probes) was
assessed using the FALCON HTS FluoroBlock transwell system
(Becton Dickinson) as described.25 Cells were placed in the inserts
(5104 per insert) in serum-free medium. The lower chamber
contained either serum-free medium supplemented with 0.1% BSA
(unstimulated cells) or the chemotactic agent (10% FBS and 10%
NCS for VSMCs and NIH-3T3 cells, respectively). The extent of cell
migration was estimated by the fluorescence in the lower chamber,
which was measured using a Victor 4120 multilabel counter (Wal-
lac). Results represent the average fluorescence of induced cells
(n3) after subtracting the fluorescence of unstimulated cells (n2).
Immunofluorescence
Cells were seeded on glass coverslips and serum-starved in 0.2%
FBS for 2 days. When indicated, cells were challenged with a 0.8%
agarose plug in PBS containing 50% FBS after serum starvation. The
coverslips were washed with PBS, fixed in 4% paraformaldehyde/
PBS, and permeabilized with 0.5% Triton X-100/PBS. After block-
ing with 1% BSA/PBS, cells were incubated for 90 minutes with
TRITC-conjugated phalloidin (1:500, Sigma) to label actin filaments
and/or anti-paxillin antibody (1:200, clone 349, Transduction Labo-
ratories). A mouse monoclonal antibody was used for p27 expression
(DSC-72.F6, Master Diagnostica). Immunocomplexes were detected
with biotinylated anti-mouse antibody (1:600, E0413, DAKO) fol-
lowed by streptavidin-FITC (1:600, F0422, DAKO) or streptavidin–
Texas Red (1:600, 5-872, Molecular Probes). Microscopic images
were digitally recorded on an Axioscope II microscope (Zeiss).
Confocal microscopy was performed at the SCSIE (University of
Valencia) using a TCS SP LEICA microscope and VISILOG.5
software.
Statistical Analysis
Results are reported as meanSEM. Unless otherwise stated, differ-
ences were evaluated by ANOVA and Fisher post hoc test. Statisti-
cally significant differences were considered at P0.05.
Results
Effect of p27Kip1 on Focal Adhesions and
Cytoskeletal Architecture
Using transwell migration assays, we have previously dem-
onstrated the antimigratory activity of p27Kip1 in primary
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cultures of HUVECs25 and rabbit VSMCs.27 Because cell
locomotion is a complex dynamic process that requires
changes in the distribution of focal adhesions (FAs) and
reorganization of the actin cytoskeleton,29 we investigated the
effect of p27 overexpression on these processes by infecting
cells with Rev-p27. Control cultures were infected with
Rev-LacZ. Preliminary Western blot analysis revealed a 2.6-
to 4.2-fold increase in p27Kip1 expression in rat VSMCs
(E19P) and murine fibroblasts (NIH-3T3) infected with
Rev-p27 (Figures 1A and 1B). In uninfected E19P cells, the
endogenous p27Kip1 protein level was 3.1-fold higher in highly
confluent versus subconfluent cultures (Figure 1A), and
NIH-3T3 cells maintained in 0.5% FBS increased p27Kip1
expression by 3.8-fold compared with cultures fed 10% FBS
(data not shown). Thus, retrovirally expressed p27Kip1 accu-
mulated to physiologically high levels. Indirect immunofluo-
rescence experiments revealed consistent and uniform over-
expression of p27Kip1 in Rev-p27–infected cells (Figure 1C).
Serum-starved NIH-3T3 fibroblasts infected with either
Rev-p27 or Rev-LacZ displayed a flat nonpolarized shape
with a similar organization of actin filaments (Figure 2A) and
widespread distribution of the FA-associated protein paxillin
(Figure 2B). We next examined well-defined characteristics
of migrating cells in cultures challenged with a chemotactic
stimulus, including cell polarization with the formation of
lamellipodia, redistribution of FAs toward these protrusions,
and reorganization of the actin cytoskeleton.29 Analysis of
stimulated cultures infected with control Rev-LacZ revealed
the appearance of polarized cells that accumulated FAs
within the lamellipodial protrusions (Figure 2E). Moreover,
confocal microscopy of polarized cells revealed the charac-
teristic organization of actin filaments in migrating cells, with
long actin filaments oriented parallel to the long axis and a
network of diagonally linked actin filaments within the
lamellipodia (Figure 2D, left), in contrast to the pattern of
relatively short actin filaments arranged in multiple orienta-
tions seen in nonpolarized cells (Figure 2D, right). Cells with
an unambiguous migratory phenotype were also observed in
stimulated cultures infected with Rev-p27; however, their
frequency was relatively low compared with Rev-LacZ–
infected NIH-3T3 cells (174.6% versus 461.4%, respec-
tively) (Figure 2C).
Although polarization in stimulated E19P cells was not as
evident as in NIH-3T3 cells, we also noted redistribution of
FAs in E19P cultures (Figure 2F; compare left panel showing
accumulation of paxillin expression in opposite poles versus
widespread expression in the right panel). Moreover, in
agreement with the results with NIH-3T3 cells, E19P cells
displaying redistribution of FAs were more frequent in
cultures infected with Rev-LacZ compared with Rev-p27
(593.6% versus 292.2%, respectively) (Figure 2F).
Augmented cell size was noticeable on infection with
Rev-p27, an effect that was exacerbated in mitogen-
stimulated cultures (Figure 2; compare Rev-LacZ– and Rev-
p27–infected cultures in the absence and presence of chemo-
tactic stimulus). We scored the number of cells that visibly
exceeded the average population size in stimulated cultures.
This analysis disclosed 241.2% and 81.5% of hypertro-
phic Rev-p27– and Rev-LacZ–infected NIH-3T3 cells, re-
spectively (Figure 2C). Likewise, 401.4% of E19P-
stimulated cells infected with Rev-p27 were clearly
hypertrophic compared with 120.8% of hypertrophic Rev-
LacZ–infected cells (Figure 2F). These results are in agree-
ment with previous studies showing that p27Kip1 overexpres-
sion induced hypertrophy in mitogen-stimulated VSMCs and
that angiotensin II–mediated VSMC hypertrophy required a
high level of p27Kip1 expression.30,31
The above-mentioned experiments extend our previous
studies illustrating the antimigratory activity of p27Kip1 in
transwell migration assays25,27 by demonstrating that p27Kip1
can alter the phenotypic modulation that normally occurs
during cell locomotion (eg, lamellipodia formation and reor-
ganization of actin filaments and FAs). In the presence of
serum, adhesion of NIH-3T3 and E19P cells to culture dishes
was similar when uninfected cultures were compared with
either Rev-p27– or Rev-LacZ–infected cells (Figure 3).
Likewise, Rev-p27 did not affect the adhesion of rat primary
VSMCs compared with cells infected with Rev-LacZ. Thus,
Figure 1. Infection of VSMCs and fibroblasts with
retroviral vectors leads to physiologically high level
of p27Kip1 expression. A, Western blot analysis of
uninfected and Rev-p27–infected E19P cells har-
vested at the indicated densities. Numbers show
the results of densitometric analysis to determine
the relative expression level of p27Kip1 after correct-
ing by CDK2 expression (uninfected subconfluent
cells1). B, Subconfluent infected NIH-3T3 cells
analyzed as in panel A. Two different experiments
are shown. C, Indirect inmmunofluorescence anal-
ysis of p27Kip1 expression in Rev-LacZ– and Rev-
p27–infected NIH-3T3 cells.
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defective cell adhesion does not seem to account for p27Kip1-
dependent migration blockade in cells stimulated with serum
(Figure 2).
p27Kip1-Dependent Growth Arrest and Migration
Blockade Require Inhibition of CDK Activity
The p27CK mutant protein displays impaired CDK inhib-
itory activity and lack of growth-suppressive function.28
To investigate whether growth arrest and migration block-
ade are separate functions of p27Kip1, we compared in E19P
and NIH-3T3 cells the effect of Rev-p27 and Rev-p27CK
on growth factor–stimulated proliferation and locomotion.
The level of overexpression achieved on infection with
Rev-p27CK was similar to that obtained with Rev-p27
(Figure 1B and data not shown). As expected, Rev-p27 but
not Rev-p27CK reduced CDK activity (Figure 4A). Con-
sistent with these findings, infection of NIH-3T3 and E19P
cells with Rev-p27 inhibited [3H]thymidine incorporation
compared with that in uninfected cells or in cultures
infected with control Rev-LacZ (Figure 4B). In contrast,
Rev-p27CK slightly increased de novo DNA synthesis.
We next examined cell migration using a transwell
assay. Preliminary control experiments in NIH-3T3 cells
and rat primary VSMCs demonstrated similar migratory
capacities of uninfected and Rev-LacZ–infected cultures
over a stimulation period of 8 hours (Figure 5A). Under
these conditions, infection of E19P cells, NIH-3T3 cells,
and rat primary VSMCs with Rev-p27, but not Rev-
Figure 2. Effect of p27Kip1 on the distribution of paxillin expression and cytoskeletal architecture. Immunofluorescence analysis of NIH-
3T3 (A through E) and E19P (F) cells maintained for 2 days in media containing 0.2% FBS (no chemotactic stimulus) or challenged with
a 0.8% agarose plug in PBS containing 50% FBS after serum starvation (chemotactic stimulus). Nuclei were counterstained with
Hoechst 33258. A, Actin filaments in unstimulated cells visualized with TRITC-conjugated phalloidin. B, Double immunofluorescence
showing the FA-associated protein paxillin (green) and actin filaments (red). C, Visualization of actin filaments in stimulated NIH-3T3
cultures. Cells with lamellipodial protrusions characteristic of the migratory phenotype (asterisks) were more abundant in Rev-LacZ–
compared with Rev-p27–infected cultures. In contrast, cells visibly hypertrophic (arrowhead) were more frequent on infection with Rev-
p27. The total number of cells scored from 2 independent coverslips in each condition is indicated (n). D, Confocal microscopy show-
ing the organization of actin filaments in stimulated NIH-3T3 cells infected with Rev-LacZ and Rev-p27. E, Accumulation of paxillin
(green) within the lamellipodial protrusion (asterisk) of a polarized NIH-3T3 cell from a culture dish infected with Rev-LacZ. F, Immuno-
fluorescence analysis of paxillin (red) in stimulated E19P cells revealing migrating cells as those that redistributed this FA-associated
protein toward opposite poles, in contrast to cells that displayed widespread paxillin expression. Like in NIH-3T3 cells, migratory and
hypertrophic phenotypes in stimulated E19P cultures were more frequent on infection with Rev-LacZ and Rev-p27, respectively. The
total number of cells scored from 2 independent coverslips in each condition is indicated (n).
Díez-Juan and Andrés Control of Cell Cycle and Migration by p27Kip1/pRb 405
p27CK, markedly inhibited serum-induced cell migration
(Figure 5B). Of note, p27Kip1 also inhibited platelet-derived
growth factor (PDGF)-BB– dependent migration of human
vein endothelial cells25 and VSMCs (please see the online
data supplement, available at http://www.circresaha.org)
in transwell assays.
pRb Status Coordinately Regulates Cell
Proliferation and Migration
The above-described results demonstrate that CDK inhibition
is essential for the dual function of p27Kip1 as a growth
suppressor and migration blocker. Thus, we reasoned that
downstream targets of CDK activity might contribute to
coordinately regulate cell cycle progression and locomotion.
Because CDK-dependent hyperphosphorylation of pRb is
critical for cell cycle progression,4 we investigated whether
pRb can affect cell migration. We first examined the effect of
Rb-HAp34, a phosphorylation-deficient pRb mutant insen-
sitive to CDK-dependent inactivation.32 As expected, cultures
of asynchronously growing NIH-3T3 cells infected with
Rev-Rb-HAp34 disclosed a dramatic reduction in [3H]thy-
midine incorporation versus Rev-LacZ–infected cells (Figure
6A). The antiproliferative effect of Rb-HAp34 was mark-
edly correlated with a diminished migratory capacity (Figure
6B).
If inhibition of CDK-mediated pRb hyperphosphorylation
contributes to the antimigratory function of p27Kip1, as sug-
gested by the above results, one would expect high prolifer-
ative and migratory activity by inactivating pRb function
even in the presence of high level of p27 expression and
reduced CDK activity. To test this possibility, NIH-3T3 cells
were doubly infected with Rev-p27 and Rev-E1A, which
encodes for the adenovirus E1A oncoprotein. In previous
studies with rodent fibroblasts and cardiac myocytes, E1A
has been shown to associate with the growth suppressor pRb,
thus alleviating pRb-mediated repression of E2F transcrip-
tional activity and evoking cell cycle progression.33,34 These
studies also demonstrated the ability of E1A in preventing
growth arrest by p21Cip1 and p27Kip1 without increasing CDK
activity. Consistent with these findings, Rev-E1A overcame
the proliferative blockade by high level of p27Kip1 expression
(Figure 7A) without restoring CDK activity (Figure 7B).
Importantly, Rev-E1A restored cell migration in cultures
coinfected with Rev-p27 (Figure 7C).
Discussion
In the present study, we have identified molecular mecha-
nisms that regulate cell proliferation and migration in a
coordinated manner (Figure 8). Our results suggest that
changes in p27Kip1 expression within the physiological range
might concomitantly regulate VSMC and fibroblast growth
and locomotion. A low level of p27Kip1 expression was
correlated with high proliferative and migratory capacity,
whereas nuclear accumulation of this CKI was associated
with a quiescent and static phenotype. The observation that
blockade of CDK activity was essential for this dual inhibi-
tory function of p27Kip1 (Figure 5B) suggests that modulation
of CDK/cyclin activity may coordinately control cell prolif-
eration and locomotion. Indeed, migration induced by
PDGF-BB was maximal in VSMCs that were predominantly
in late G1,35 a phase of the cell cycle associated with high
CDK activity. Moreover, CDK5 and CDK6 appear to regu-
late several processes that are relevant for cell migration.36–39
McAllister et al40 have recently reported that efficient
transduction of a misfolded TAT-p27Kip1 fusion protein into
HepG2 human hepatocellular carcinoma cells induces cell
Figure 3. Rev-p27 did not affect cell attachment. Cells (2104)
were plated on 6-well tissue culture plates. Media contained
10% NCS (NIH-3T3) or 10% FBS (E19P, primary VSMCs). Wells
were washed after 1.5 hours, and attached cells were
trypsinized and counted with a hemocytometer (n3). Results
are expressed relative to Rev-LacZ–infected cells (n1). Differ-
ences among groups were not significant (P0.05) as revealed
by ANOVA and Fisher post hoc test (NIH-3T3, E19P) or two-
tailed unpaired Student t test (primary VSMCs).
Figure 4. Effect of Rev-p27 and Rev-p27CK on CDK activity
and cell proliferation. A, Lysates of NIH-3T3 cells infected as
indicated were immunoprecipitated with antibodies against
cyclin E and cyclin A to determine in vitro the associated CDK
activity. B, [3H]Thymidine incorporation assays in asynchro-
nously growing cells are shown. For simplicity, only statistically
significant differences vs uninfected cells are shown: *P0.05,
**P0.005, and ***P0.001.
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scattering, a finding that seemingly disagrees with the present
study. However, it is important to note that this activity of
TAT-p27Kip1 occurred without causing cell cycle arrest be-
cause of the cytoplasmic accumulation of TAT-p27Kip1 and
the lack of association with CDK/cyclin complexes. Impor-
tantly, a mutant TAT-p27Kip1 protein that accumulated in the
nucleus failed to induce cell migration. In the present study,
Rev-p27 led to nuclear accumulation of p27Kip1 (Figure 1C),
and p27Kip1-dependent migration blockade required inactiva-
tion of CDK/cyclin complexes and growth arrest.
Because pRb is a critical target of CDKs from mid G1
through S phase, we examined whether this growth suppres-
sor can regulate cell migration. Forced expression of Rb-
HAp34, a pRb mutant refractory to CDK-dependent hyper-
phosphorylation that prevents transcriptional activation of
promoters containing the E2F-binding motif,32,41 evoked a
quiescent and static phenotype (Figure 6). Conversely, the
oncoprotein E1A, which can trigger cell proliferation by
alleviating pRb-mediated repression of E2F transcriptional
activity in a CDK-independent manner,33,34 overcame p27Kip1-
dependent growth arrest and migration blockade without
restoring CDK activity (Figure 7). Thus, p27Kip1-dependent
growth suppression and inhibition of migration may be
mediated by the accumulation of hypophosphorylated pRb
and repression of E2F target genes. Of note in consideration
of this model, E2F-1–null keratinocytes exhibited a delay in
transit through both G1 and S phases of the cell cycle and
substantially impaired migration.42
The interrelationships between cell cycle and cell locomo-
tion appear to be a general phenomenon. For example, the
growth suppressors p27Kip1, p16INK4a, and p21Cip1 are potent
inhibitors of cell spreading and migration in a variety of cell
types, including HUVECs, CS-1 3 melanoma cells,
VSMCs, and NIH-3T3 fibroblasts25–27,36 (also shown in the
present study). Moreover, several cytostatic agents (eg, quer-
cetin, mimosine, suramin, rapamycin, and troglitazone) re-
duced the migratory potential of VSMCs and tumor cells.43–48
Likewise, 17-estradiol concurrently regulated cell growth
and locomotion, leading to increased endothelial cell prolif-
eration and migration and blockade of the chemotactic and
mitogenic effects of PDGF-BB in VSMCs.49 Inactivation of
activator protein-1 and c-myc transcription factors also inhib-
ited both proliferation and migration of cultured VSMCs,50,51
and p53-deficient VSMCs displayed a higher rate of prolif-
eration and migration than wild-type counterparts.52 It is
noteworthy that NBT-II rat bladder carcinoma cells synchro-
nized in G1 migrated simultaneously after fibroblast growth
factor-1 stimulation.53 Moreover, cell movement was ob-
served in all phases of the cell cycle, except G2/M, in which
cells did not respond to stimulation by fibroblast growth
Figure 6. Constitutively active pRb
mutant refractory to CDK-dependent
hyperphosphorylation causes growth
arrest and migration blockade in NIH-
3T3 cells. A, [3H]Thymidine incorporation
assays in asynchronously growing cells.
Differences were analyzed by two-tailed
unpaired Student t test. B, Migration
assay using the transwell system. For
simplicity, only statistical comparisons
versus the initial value are shown for
each retroviral construct.
Figure 5. CDK inhibition is required for
p27Kip1-dependent migration blockade.
Cells infected as indicated were plated in
the upper chamber of a transwell sys-
tem. Results represent the average fluo-
rescence of mitogen-induced cells (n3)
after subtracting the fluorescence of
unstimulated cells (n2) (see Materials
and Methods for details). For simplicity,
only statistical comparisons versus the
initial value are shown for each retroviral
construct. Except in primary VSMCs,
Rev-p27–infected cells did not migrate
significantly over the time period ana-
lyzed. A, Control experiments comparing
uninfected and Rev-LacZ–infected cells.
B, Effect of Rev-p27 and Rev-p27CK on
cell migration.
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factor-1.53 Fukui et al35 demonstrated maximal migration of
PDGF-BB–stimulated VSMCs in late G1. Moreover, tran-
scriptional profiling of human fibroblasts has identified di-
verse cytoskeletal reorganization genes and many genes
involved in cell motility and remodeling of the extracellular
matrix that exhibit cell cycle–dependent regulation.54 Thus,
the position in the cell cycle appears to be a major determi-
nant of the competence of a cell for migration.
In conclusion, we propose that cellular proliferation and
migration are regulated in a coordinated manner by the
p27Kip1/CDK/pRb/E2F pathway. Further clarification of the
molecular networks underlying the interrelationships between
cell cycle–regulatory factors and the chemotactic machinery
should shed significant mechanistic insight into the pathobi-
ology of neointimal lesion development, thus facilitating the
development of novel therapies for the treatment of vascular
occlusive disorders.
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